“Most of the cannabinoids in Cannabis sativa L. have not been fully evaluated for their pharmacological activity.
A publication in this issue presents evidence that a plant cannabinoid, Δ9-tetrahydrocannabivarin is a potent antagonist of anandamide, a major endogenous cannabinoid.
It seems possible that many of the non-psychoactive constituents of this plant will be of biological interest.
I sincerely believe that the plant cannabinoids are a neglected pharmacological treasure trove.”